Systemic in vivo antitumor activity of interleukin-12 against both transplantable and primary tumor

被引：14
|
作者：
Nishimura, T
Watanabe, K
Lee, U
Yahata, T
Ando, K
Kimura, M
Hiroyama, Y
Kobayashi, M
Herrmann, SH
Habu, S
机构：
[1] TOKAI UNIV,SCH MED,DEPT INFECT DIS,ISEHARA,KANAGAWA 25911,JAPAN
[2] TOKAI UNIV,SCH MED,DEPT MOLEC LIFE SCI,ISEHARA,KANAGAWA 25911,JAPAN
[3] DNARD INC,KAWASAKI,KANAGAWA 216,JAPAN
[4] GENET INST INC,CAMBRIDGE,MA 02140
来源：
IMMUNOLOGY LETTERS | 1995年 / 48卷 / 02期
关键词：
interleukin-12; tumor immunotherapy; primary tumor; mouse;
D O I：
10.1016/0165-2478(95)02448-4
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
[No abstract available]
引用
收藏
页码：149 / 152
页数：4
相关论文
共 50 条
  • [1] Antitumor activity of interleukin-12 against murine bladder cancer
    Eto, M
    Harada, M
    Tamada, K
    Tokuda, N
    Koikawa, Y
    Nakamura, M
    Nomoto, K
    Naito, S
    JOURNAL OF UROLOGY, 2000, 163 (05): : 1549 - 1552
  • [2] ANTITUMOR AND ANTIMETASTATIC ACTIVITY OF INTERLEUKIN-12 AGAINST MURINE TUMORS
    BRUNDA, MJ
    LUISTRO, L
    WARRIER, RR
    WRIGHT, RB
    HUBBARD, BR
    MURPHY, M
    WOLF, SF
    GATELY, MK
    JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 178 (04): : 1223 - 1230
  • [3] ANTITUMOR-ACTIVITY OF INTERLEUKIN-12
    BRUNDA, MJ
    GATELY, MK
    CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1994, 71 (03): : 253 - 255
  • [4] Antitumor and antimetastatic activity of interleukin-12
    Hendrzak, JA
    Brunda, MJ
    ATTEMPTS TO UNDERSTAND METASTASIS FORMATION III: THERAPEUTIC APPROACHES FOR METASTASIS TREATMENT, 1996, 213 : 65 - 83
  • [5] Antitumor activity of killer cells stimulated with both interleukin-2 and interleukin-12 on mouse glioma cells
    Kikuchi, T
    Joki, T
    Abe, T
    Ohno, T
    JOURNAL OF IMMUNOTHERAPY, 1999, 22 (03): : 245 - 250
  • [6] Bioactive murine and human interleukin-12 fusion proteins which retain antitumor activity in vivo
    Lieschke, GJ
    Rao, PK
    Gately, MK
    Mulligan, RC
    NATURE BIOTECHNOLOGY, 1997, 15 (01) : 35 - 40
  • [7] Bioactive murine and human interleukin-12 fusion proteins which retain antitumor activity in vivo
    Graham J. Lieschke
    Prakash K. Rao
    Maurice K. Gately
    Richard C. Mulligan
    Nature Biotechnology, 1997, 15 : 35 - 40
  • [8] Enhancement of the antitumor activity of interleukin-12 by targeted delivery to neovasculature
    C. Halin
    S. Rondini
    F. Nilsson
    A. Berndt
    H. Kosmehl
    L. Zardi
    D. Neri
    Nature Biotechnology, 2002, 20 : 264 - 269
  • [9] Enhancement of the antitumor activity of interleukin-12 by targeted delivery to neovasculature
    Halin, C
    Rondini, S
    Nilsson, F
    Berndt, A
    Kosmehl, H
    Zardi, L
    Neri, D
    NATURE BIOTECHNOLOGY, 2002, 20 (03) : 264 - 269
  • [10] Evaluation of the antitumor activity of the interleukin-12 pulse interleukin-2 combination
    Wigginton, JM
    Komschlies, KL
    Green, JE
    Cox, GW
    Jorcyk, CL
    Back, TC
    Franco, JL
    Brunda, MJ
    Wiltrout, RH
    INERLEUKIN 12: CELLULAR AND MOLECULAR IMMUNOLOGY OF AN IMPORTANT REGULATORY CYTOKINE, 1996, 795 : 434 - 439
12345